Cytogenetic methods for detection of oxidative stress and evaluation of antioxidant therapy in hepatitis C infection

Hepatitis Monthly

Volumn 11, Issue 6, 2011, Pages 434-439

  Emerit, Ingrid ^a  

^a CNRS   (France)

Author keywords

Cytogenetic; Hepatitis C virus; Oxidative stress

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIOXIDANT; ANTIOXIDANT BIOFACTOR; CLASTOGEN; CLASTOGENIC FACTOR; PRESERVATIVE; SUPEROXIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANALYTIC METHOD; BLOOD EXAMINATION; BLOOD FILTRATION; CANCER RISK; CARCINOGENESIS; CELL ACTIVITY; CHROMOSOME ABERRATION; CULTURE MEDIUM; CYTOGENETICS; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; NONHUMAN; OXIDATIVE STRESS; REVIEW;

EID: 79960316417     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. von Herbay A, Stahl W, Niederau C, Sies H. Vitamin E improves the aminotransferase status of patients suffering from viral hepatitis C: a randomized, double-blind, placebo-controlled study. Free Radic Res. 1997;27(6):599-605.
2. Look MP, Gerard A, Rao GS, Sudhop T, Fischer HP, Sauerbruch T, et al. Interferon/antioxidant combination therapy for chronic hepatitis C-a controlled pilot trial. Antiviral Res. 1999;43(2):113-22.
3. Seeff LB, Lindsay KL, Bacon BR, Kresina TF, Hoofnagle JH. Complementary and alternative medicine in chronic liver disease. Hepatology. 2001;34(3):595-603.
4. Valgimigli L, Valgimigli M, Gaiani S, Pedulli GF, Bolondi L. Measurement of oxidative stress in human liver by EPR spinprobe technique. Free Radic Res. 2000;33(2):167-78.
5. Chen MF, Mo LR, Lin RC, Kuo JY, Chang KK, Liao C, et al. Increase of resting levels of superoxide anion in the whole blood of patients with decompensated liver cirrhosis. Free Radic Biol Med. 1997;23(4):672-9.
6. Emerit I, Serejo F, Filipe P, Alaoui Youssefi A, Fernandes A, Costa A, et al. Clastogenic factors as biomarkers of oxidative stress in chronic hepatitis C. Digestion. 2000;62(2-3):200-7.
7. Emerit I. Clastogenic factors as potential biomarkers of increased superoxide production. Biomark Insights. 2007;2:429-38.
8. Emerit I, Garban F, Vassy J, Levy A, Filipe P, Freitas J. Superoxidemediated clastogenesis and anticlastogenic effects of exogenous superoxide dismutase. Proc Natl Acad Sci U S A. 1996;93(23):12799-804.
9. Jaeschke H, Bautista AP, Spolarics Z, Spitzer JJ. Superoxide generation by neutrophils and Kupffer cells during in vivo reperfusion after hepatic ischemia in rats. J Leukoc Biol. 1992;52(4):377-82.
10. Larrea E, Garcia N, Qian C, Civeira MP, Prieto J. Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C. Hepatology. 1996;23(2):210-7.
11. Maeda H, Akaike T. Oxygen free radicals as pathogenic molecules in viral diseases. Proc Soc Exp Biol Med. 1991;198(2):721-7.
12. Ungerer JP, Oosthuizen HM, Bissbort SH, Vermaak WJ. Serum adenosine deaminase: isoenzymes and diagnostic application. Clin Chem. 1992;38(7):1322-6.
13. De Maria N, Colantoni A, Fagiuoli S, Liu GJ, Rogers BK, Farinati F, et al. Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radic Biol Med. 1996;21(3):291-5.
14. Paradis V, Mathurin P, Kollinger M, Imbert-Bismut F, Charlotte F, Piton A, et al. In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features. J Clin Pathol. 1997;50(5):401-6.
15. Emerit I, Huang CY, Serejo F, Filipe P, Fernandes A, Costa A, et al. Oxidative stress in chronic hepatitis C: a preliminary study on the protective effects of antioxidant flavonoids. Hepatogastroenterology. 2005;52(62):530-6.
16. Emerit I, Serejo F, Carneiro de Moura M. Clastogenic factors in the plasma of patients with hepatitis C: their possible role at the origin of hepatocarcinoma. Cancer Genet Cytogenet. 2007;179(1):31-5.
17. Goh K, Sumner H. Breaks in normal human chromosomes: are they induced by a transferable substance in the plasma of persons exposed to total-body irradiation? Radiat Res. 1968;35(1):171-81.
18. Lehnert BE, Goodwin EH, Deshpande A. Extracellular factor(s) following exposure to alpha particles can cause sister chromatid exchanges in normal human cells. Cancer Res. 1997;57(11):2164-71.
19. German J. Patterns of neoplasia associated with the chromosomebreakage syndromes. Chromosome Mutation Neoplasia. 1983:97-134.
20. Emerit I. Reactive oxygen species, chromosome mutation, and cancer: possible role of clastogenic factors in carcinogenesis. Free Radic Biol Med. 1994;16(1):99-109.
21. Weedon DD, Shorter RG, Ilstrup DM, Huizenga KA, Taylor WF. Crohn's disease and cancer. N Engl J Med. 1973;289(21):1099-103.
22. Roumm AD, Medsger TA, Jr. Cancer and systemic sclerosis. An epidemiologic study. Arthritis Rheum. 1985;28(12):1336-40.
23. Barnes BE, Mawr B. Dermatomyositis and malignancy. A review of the literature. Ann Intern Med. 1976;84(1):68-76.
24. Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DG, et al. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst. 1993;85(4):307-11.
25. Pettersson T, Pukkala E, Teppo L, Friman C. Increased risk of cancer in patients with systemic lupus erythematosus. Ann Rheum Dis. 1992;51(4):437-9.
26. Emerit I, Feingold J, Levy A, Martin E, Housset E. Tumor incidence and development of autoimmune hemolytic anemia in two breeding lines of the NZB mouse strain that differ in chromosome breakage. J Natl Cancer Inst. 1980;64(3):513-7.
27. Crawford D, Zbinden F, Amstad P, Cerutti P. Oxidant stress induces the proto-oncogenes c-fos and c-myc in mouse epiderma cells. Oncogene. 1988;3:27-32.